About: Pupillometry in healthy volunteers as a biomarker of tramadol efficacy     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:seeAlso
Description
  • What is known and Objective: The opioid effect of tramadol, which can be detected by pupillary response, is predominantly mediated by the O-demethylated metabolite, formed via CYP2D6. This study was designed to evaluate the effects of tramadol using different parameters of pupillometry as biomarkers. Methods: Sixty-nine healthy volunteers received tramadol hydrochloride drops orally at a dose of 0.7 mg/kg. Pre-dose and 2-h post-dose pupillometric measurements were performed. The polymorphism of CYP2D6 was analysed. Results and Discussion: Large interindividual variability was observed in the tramadol-induced pupillary reaction. Miosis was induced in 69.6% and mydriasis in 30.4% of the subjects. The pupillary response differed in relation to the CYP2D6 genotype. A maximal difference in initial pupil diameter of 0.81 mm was found in extensive metabolizers. There were significant effects observed on the pupillary light reflex parameters with tramadol administration (P < 0.05) except for the reflex amplitude and constriction velocity. What is new and Conclusion: The pharmacodynamic effects of tramadol were easily detected using both static and dynamic pupil parameters. The pharmacodynamic profiles were markedly influenced by the CYP2D6 phenotype.
  • What is known and Objective: The opioid effect of tramadol, which can be detected by pupillary response, is predominantly mediated by the O-demethylated metabolite, formed via CYP2D6. This study was designed to evaluate the effects of tramadol using different parameters of pupillometry as biomarkers. Methods: Sixty-nine healthy volunteers received tramadol hydrochloride drops orally at a dose of 0.7 mg/kg. Pre-dose and 2-h post-dose pupillometric measurements were performed. The polymorphism of CYP2D6 was analysed. Results and Discussion: Large interindividual variability was observed in the tramadol-induced pupillary reaction. Miosis was induced in 69.6% and mydriasis in 30.4% of the subjects. The pupillary response differed in relation to the CYP2D6 genotype. A maximal difference in initial pupil diameter of 0.81 mm was found in extensive metabolizers. There were significant effects observed on the pupillary light reflex parameters with tramadol administration (P < 0.05) except for the reflex amplitude and constriction velocity. What is new and Conclusion: The pharmacodynamic effects of tramadol were easily detected using both static and dynamic pupil parameters. The pharmacodynamic profiles were markedly influenced by the CYP2D6 phenotype. (en)
Title
  • Pupillometry in healthy volunteers as a biomarker of tramadol efficacy
  • Pupillometry in healthy volunteers as a biomarker of tramadol efficacy (en)
skos:prefLabel
  • Pupillometry in healthy volunteers as a biomarker of tramadol efficacy
  • Pupillometry in healthy volunteers as a biomarker of tramadol efficacy (en)
skos:notation
  • RIV/00064165:_____/11:9530!RIV12-MZ0-00064165
http://linked.open...avai/predkladatel
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I, Z(MSM0021620849)
http://linked.open...iv/cisloPeriodika
  • 4
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 225276
http://linked.open...ai/riv/idVysledku
  • RIV/00064165:_____/11:9530
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • CYP2D6; pharmacodynamics; pharmacogenetics; pupillometry; tramadol; alzheimers-disease; cyp2d6 polymorphism; pupillary response; pharmacokinetics; morphine; tropicamide; light (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV
  • [C04038D1E068]
http://linked.open...i/riv/nazevZdroje
  • Journal of Clinical Pharmacy and Therapeutics
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 36
http://linked.open...iv/tvurceVysledku
  • Chytil, Lukáš
  • Slanař, Ondřej
  • Matoušková, Olga
  • Perlík, František
http://linked.open...ain/vavai/riv/wos
  • 000292464300008
http://linked.open...n/vavai/riv/zamer
issn
  • 0269-4727
number of pages
is http://linked.open...avai/riv/vysledek of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software